We are live on
!
Find out more
KA
Kearns & Associates Portfolio holdings
AUM
$214M
1-Year Est. Return
23.8%
This Fund
S&P 500
This Quarter
Est. Return
+8.22%
1 Year Est. Return
+23.8%
3 Year Est. Return
+69.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$129M
AUM Growth
+$11.8M
(+10%)
Cap. Flow
+$2.01M
Cap. Flow
% of AUM
1.55%
Top 10 Holdings %
Top 10 Hldgs %
88.52%
Holding
45
New
3
Increased
6
Reduced
3
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.07M |
| 2 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$710K |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$694K |
| 4 |
Herbalife
HLF
|
+$612K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$192K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$600K |
| 2 |
MetLife
MET
|
+$331K |
| 3 |
Comcast
CMCSA
|
+$263K |
| 4 |
Cisco
CSCO
|
+$202K |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$49.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.4% |
| 2 | Financials | 3.91% |
| 3 | Communication Services | 1.41% |
| 4 | Healthcare | 1.4% |
| 5 | Energy | 0.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Wells Fargo
WFC
$266B
| $406K | 0.31% |
7,000
| – | – |
|
27
JPMorgan Chase
JPM
$937B
| $393K | 0.3% |
1,960
| – | – |
|
28
Walt Disney
DIS
$170B
| $370K | 0.29% |
3,020
| – | – |
|
29
Stryker
SYK
$131B
| $344K | 0.27% |
960
| – | – |
|
30
Capital One
COF
$134B
| $323K | 0.25% |
2,170
| – | – |
|
31
Qualcomm
QCOM
$159B
| $323K | 0.25% |
1,905
| – | – |
|
32
iShares Core S&P 500 ETF
IVV
$884B
| $318K | 0.25% |
605
| – | – |
|
33
Equinix
EQIX
$102B
| $318K | 0.25% |
385
| – | – |
|
34
ConocoPhillips
COP
$145B
| $316K | 0.24% |
2,482
| – | – |
|
35
Johnson Controls International
JCI
$88.7B
| $294K | 0.23% |
4,500
| – | – |
|
36
Lowe's Companies
LOW
$119B
| $255K | 0.2% |
1,000
| – | – |
|
37
Baker Hughes
BKR
$60.4B
| $251K | 0.19% |
7,500
| – | – |
|
38
Danaher
DHR
$139B
| $227K | 0.18% |
910
| – | – |
|
39
Johnson & Johnson
JNJ
$613B
| $221K | 0.17% |
1,400
| – | – |
|
40
Union Pacific
UNP
$173B
| $221K | 0.17% |
900
| – | – |
|
41
PROG Holdings
PRG
$1.82B
| $207K | 0.16% |
+1,000
| New | +$31.5K |
|
|
42
Bristol-Myers Squibb
BMY
$134B
| $204K | 0.16% |
+3,770
| New | +$192K |
|
|
43
Comcast
CMCSA
$87.2B
| – | – |
-6,000
| Closed | -$263K |
|
|
44
Cisco
CSCO
$457B
| – | – |
-4,000
| Closed | -$202K |
|
|
45
MetLife
MET
$62B
| – | – |
-5,000
| Closed | -$331K |
|
Similar funds
TSS
CMBA
RC
VCM
IH
IAM
CCM
VFG
Kearns & Associates's Q1 2024 Portfolio in Review
As of Q1 2024, Kearns & Associates held 45 positions worth $129M, up 10% from $117M the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Kearns & Associates's Q1 2024 filing shows 3 new, 6 increased, 3 reduced and 3 closed positions. Its largest new stake was Herbalife: 56,900 shares worth $572K. The largest sale was Vanguard S&P 500 ETF, an estimated $600K.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, down from 5.2% a quarter earlier, followed by Financials and Communication Services.
- Kearns & Associates's largest Q1 2024 buy was Herbalife: 56,900 shares worth $572K.
- Kearns & Associates added most to Vanguard FTSE Developed Markets ETF in Q1 2024, an estimated $1.07M increase.
- Kearns & Associates's biggest Q1 2024 reduction was Vanguard S&P 500 ETF, cutting an estimated $600K.
- Kearns & Associates fully exited MetLife in Q1 2024, selling an estimated $331K.
- Kearns & Associates's ten largest holdings make up 89% of its $129M portfolio in Q1 2024.
- Kearns & Associates opened 3 new positions and closed 3 in Q1 2024.
- Kearns & Associates's portfolio value rose 10% quarter-over-quarter to $129M.
Based on Kearns & Associates's 13F filing for Q1 2024, filed 10 May 2024.